130 related articles for article (PubMed ID: 7357520)
1. Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.
Rivera G; Aur RJ; Dahl GV; Pratt CB; Wood A; Avery TL
Cancer; 1980 Mar; 45(6):1284-8. PubMed ID: 7357520
[TBL] [Abstract][Full Text] [Related]
2. VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
Rivera G; Dahl GV; Bowman WP; Avery TL; Wood A; Aur RJ
Cancer; 1980 Oct; 46(8):1727-30. PubMed ID: 6932995
[TBL] [Abstract][Full Text] [Related]
3. VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.
Rivera G; Bowman WP; Murphy SB; Dahl GV; Aur RJ; Kalwinsky DK; Wood A; Stagner S; Avery TL
Med Pediatr Oncol; 1982; 10(5):439-46. PubMed ID: 6958957
[TBL] [Abstract][Full Text] [Related]
4. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Ochs J; Rivera GK; Pollock BH; Buchanan G; Crist W; Freeman AI
Cancer; 1990 Oct; 66(8):1671-7. PubMed ID: 2208021
[TBL] [Abstract][Full Text] [Related]
5. Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia.
Linker CA; Levitt LJ; O'Donnell M; Ries CA; Forman SJ
Semin Oncol; 1987 Jun; 14(2 Suppl 1):78-85. PubMed ID: 3473686
[No Abstract] [Full Text] [Related]
6. Etoposide and cytosine arabinoside combination chemotherapy for refractory acute lymphocytic leukemia in childhood.
Esumi N; Todo S; Arakawa S; Imashuku S
J Clin Oncol; 1986 Jul; 4(7):1089-93. PubMed ID: 3459812
[TBL] [Abstract][Full Text] [Related]
7. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK
J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355
[TBL] [Abstract][Full Text] [Related]
8. Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia.
Hoelzer D; Thiel E; Löffler H; Büchner T; Ganser A; Heil G; Kurrle E; Heimpel H; Koch P; Lipp T
Semin Oncol; 1987 Jun; 14(2 Suppl 1):92-7. PubMed ID: 3473688
[No Abstract] [Full Text] [Related]
9. Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Maluf PT; Odone Filho V; Cristofani LM; Britto JL; Almeida MT; Pontes E; Maksoud JG; Manissadjian A
J Clin Oncol; 1994 Sep; 12(9):1963-8. PubMed ID: 8083717
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of cytosine arabinoside (NSC-63878) and prednisone (NSC-10023) in refractory childhood lymphoblastic leukemia.
Nesbit ME; Sonley M; Hammond D
Med Pediatr Oncol; 1976; 2(1):61-8. PubMed ID: 1064743
[TBL] [Abstract][Full Text] [Related]
11. Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia.
Sanz GF; Sanz MA; Rafecas FJ; Martínez JA; Martín-Aragonés G; Marty ML
Cancer Treat Rep; 1986 Nov; 70(11):1321-3. PubMed ID: 3464352
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group.
Bleyer WA; Krivit W; Chard RL; Hammond D
Cancer Treat Rep; 1979 Jun; 63(6):977-81. PubMed ID: 380803
[TBL] [Abstract][Full Text] [Related]
13. Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.
Grem JL; Hoth DF; Leyland-Jones B; King SA; Ungerleider RS; Wittes RE
J Clin Oncol; 1988 Feb; 6(2):351-79. PubMed ID: 3276827
[TBL] [Abstract][Full Text] [Related]
14. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
Esumi N; Todo S; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
[TBL] [Abstract][Full Text] [Related]
15. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
Marín P; Grañena A; Carreras E; Sierra J; Olivé MT; Rozman C
Sangre (Barc); 1984; 29(4-A):399-404. PubMed ID: 6594782
[No Abstract] [Full Text] [Related]
16. Combination chemotherapy for children with acute lymphocytic leukemia who fail to respond to standard remission-induction therapy.
Lay HN; Ekert H; Colebatch JH
Cancer; 1975 Oct; 36(4):1220-2. PubMed ID: 1058044
[TBL] [Abstract][Full Text] [Related]
17. [Complete remission obtained in refractory acute lymphocytic leukemia using high-dose cytosine arabinoside combined with low-dose L-asparaginase].
Inagaki C; Ito K; Omori I; Shimazaki C; Nishio A; Haruyama H; Isemura T; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Feb; 12(2):379-82. PubMed ID: 3855616
[TBL] [Abstract][Full Text] [Related]
18. Continuous infusion high-dose cytosine arabinoside in refractory childhood leukemia.
Ochs J; Sinkule JA; Danks MK; Look AT; Bowman WP; Rivera G
J Clin Oncol; 1984 Oct; 2(10):1092-7. PubMed ID: 6593435
[TBL] [Abstract][Full Text] [Related]
19. L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone.
Smithson WA; Gilchrist GS; Burgert EO
Med Pediatr Oncol; 1979; 6(2):163-70. PubMed ID: 287856
[TBL] [Abstract][Full Text] [Related]
20. Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia.
Steuber CP; Levy GJ; Nix WL; Shepherd DA; Starling KA; Fernbach DJ
Med Pediatr Oncol; 1978; 5(1):33-8. PubMed ID: 311413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
